Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Renal fibroblasts from normal kidneys (NKF cells) and from kidneys with interstitial fibrosis (FKIF cells) were established from biopsy material. In primary and passage 1 cell cultures, the amount of fibroblasts was increased by a factor of 5-10 in cultures derived from kidneys with interstitial fibrosis as compared with cultures of normal origin. As tested by clonal growth and growth kinetic experiments, FKIF cells showed significant alterations in the proliferation capacity and generation time resulting in a hyperproliferative growth in primary and secondary fibroblast cultures in vitro. Two-dimensional gel electrophoresis experiments of [35S]
methionine
-labeled intracellular polypeptides revealed that FKIF cells express two proteins,
p53
/6.1 and p48/7.5, that are not present in normal kidney and skin fibroblasts. In addition, as analyzed by two-dimensional gel electrophoresis of medium supernatants of FKIF cells, two secreted proteins specific for FKIF cells could be demonstrated. Cross-feeding experiments using conditioned medium of FKIF cells on cultures of normal human skin fibroblasts (NSF cells) revealed that FKIF cells may secrete proteins into the medium or may modify preexisting serum factors that can induce hyperproliferation in normal dermal fibroblasts. As tested by serial subcultivation and clonal analysis, FKIF cells exert significant changes in the differentiation pattern of potentially mitotic fibroblasts populations.
...
PMID:Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis. 239 61
The bcr gene plays a critical role in the pathogenesis of two human leukemias associated with the Philadelphia chromosome: chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). In both instances a chimeric gene, formed between bcr and the abl protooncogene, results in expression of fused bcr-abl proteins with tyrosine kinase activity. There is controversy regarding the normal gene products of bcr. We investigated this problem by several techniques and found proteins of 190/185, 155, 135, 125, 108, 83 and 47 kDa in several human cell lines by immunoprecipitation with two distinct site-directed anti-bcr antibodies termed anti-bcr(738-753) and anti-bcr(898-911). The 190/185, 155, 125 and 108 kDa proteins were consistently detected by anti-bcr(898-911) antibodies by immunoblotting. Antibodies pre-reacted with excess bcr peptide did not detect these proteins. These proteins were labeled with [32P]orthophosphate in vivo and in vitro by [gamma 32P]ATP in immune complex kinase assays performed with anti-bcr antibodies indicating that these proteins are phosphorproteins. Following labeling in kinase assays, phosphoamino acid analyses detected both phosphoserine and phosphothreonine. In structural studies using one dimensional peptide maps derived by partial V8 protease treatment, the 185, 155, 135, 125 and 108 kDa proteins shared several peptide fragments but contained unique fragments as well. Similarly 2-dimensional maps of proteins labeled in the kinase assay exhaustively digested with trypsin, revealed homology between the 155, 135, 125, 108, and 83 kDa proteins. bcr proteins sedimented in glycerol gradients as putative complexes detected in the cytoplasm of the cell. A 47 kDa protein as well as the recently identified Ph-
P53
protein appeared to be associated with bcr proteins based on their co-sedimentation in glycerol gradients and co-immunoprecipitation with several different anti-bcr antibodies. None of the proteins exhibited a precursor-product relationship in pulse-chase experiments conducted with [35S]
methionine
. We conclude that human cells express several different bcr gene products ranging in size from 190 to 83 kDa, and that these proteins can form specific intracellular cytoplasmic complexes with other cellular proteins.
...
PMID:Characterization of bcr gene products in hematopoietic cells. 264 52
We examined synthesis of the
cellular phosphoprotein p53
in fresh bone marrow or peripheral blood cells from normal donors and from patients with leukemia, preleukemia, or other hematopoietic disorders. Lysates of cells labeled with [35S]
methionine
were immunoprecipitated with monoclonal antibodies to
p53
, and the immunoprecipitates were analyzed by NaDodSO4/polyacrylamide gel electrophoresis and autoradiography. Bone marrow or peripheral blood cells from 8 of 33 patients with hematopoietic disorders showed increased
p53
, seven of the eight occurring in cells of patients with preleukemia or acute myelogenous leukemia. Increased
p53
synthesis was not associated with
p53
gene amplification, as shown by Southern blot analysis. Synthesis of
p53
was not increased in any of nine normal human bone marrow samples or eight normal human peripheral blood granulocyte, macrophage, and lymphocyte samples. The hematopoietic cells of patients in remission or with chronic forms of leukemia did not generally synthesize elevated levels of
p53
. In addition, we found negligible
p53 mRNA
and protein expression in a variety of human myeloid leukemia lines blocked at different stages of differentiation. Southern blot analysis showed that, except for the HL-60 cells, the
p53
gene of the myeloid cell lines was intact. In view of recent evidence implicating
p53
in transformation of cultured cells, our results using fresh leukemia cells suggest that
p53
may contribute to the phenotype of certain leukemias in vivo.
...
PMID:Increased expression of p53 protein in human leukemia cells. 301 45
In most murine cells transformed by the SV40 virus, virtually all of the
cellular phosphoprotein p53
is in a complex with the SV40 T antigen. Here, we report that, in SV40-infected T-antigen-positive Balb 3T12 mouse cells, most (approximately 80%) of the
p53
is not in complex. Complex formation was determined by measuring the amounts of [35S]
methionine
-labeled
p53
which coprecipitated with T antigen when using monoclonal antibody to T antigen. The amount of complex formation was expressed as a percentage of total
p53
present, measured by the amount of
p53
precipitated with the monoclonal antibody to the
p53
. The values were confirmed by Western blotting procedure, in which the steady-state levels of the proteins were measured. In these measurements after complete precipitation with antibody to T antigen, the residual
p53
in the supernatant was precipitated by antibody to
p53
, and this amount was denoted as free
p53
. There was no significant difference seen between the [35S]
methionine
-labeled tryptic peptides of complexed and the free
p53
(or between complexed and free T antigens) as determined by two-dimensional gel electrophoresis and chromatography. Virus rescue experiments and retransformation by the rescued virus showed that there was no mutation in the SV40 DNA coding for the T antigen which could account for the lack of complex formation. Both
p53
and T antigen were underphosphorylated in cells which exhibited reduced complex formation. Tumorigenicity in syngeneic mice and anchorage-independent cell growth in culture of various cloned mouse cells with or without T antigen expression was compared. The changes in the biologic properties were explainable solely on the basis of known or expected effects of expression of the T antigen and were independent of complex formation or of absence of complex formation between
p53
and T antigen.
...
PMID:The transformation-related protein p53 is not bound to the SV40 T antigen in BALB 3T12 cells expressing T antigen. 302 65
The ras oncogene products require membrane localization for their function, and this is thought to be accomplished by the addition of a palmitoyl group to a cysteine residue near the carboxyl terminus of the nascent chain. A lipidated carboxyl-terminal cysteine residue is also found in sequence-related yeast sex factors, and in at least two cases, the alpha-carboxyl group is also methyl esterified. To determine if ras proteins are themselves modified by a similar type of methylation reaction, we incubated rat embryo fibroblasts transformed with
p53
and activated Ha-ras oncogenes with L-[methyl-3H]
methionine
under conditions in which the isotope was converted to the methyl donor S-adenosyl-L-[methyl-3H]
methionine
. By using an assay that detects methyl ester linkages, we found that immunoprecipitated ras proteins are in fact esterified and that the stability of these esters is consistent with a carboxyl-terminal localization. This methylation reaction may be important in regulating the interaction of ras proteins with plasma membrane components. The presence of analogous carboxyl-terminal tetrapeptide sequences in other proteins may provide a general recognition sequence for lipidation and methylation modification reactions.
...
PMID:Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. 329 Sep
In cancer cells the control over the genetic message involved in the induction of mitosis is irreversibly lost. This fact is indicated by certain phenomena displayed by cancer cells under restricted nutritional conditions. Cells transformed by DNA viruses (which stabilize "p53") keep on cycling and die. In starving cells at the inside of tumors the synthesis of pre-rRNA still proceeds while all other anabolic processes are already at a standstill. The reason is that glutamine, glycine and aspartate are channelled into the enzymatic pathways for the synthesis of nucleosides: thus, protein synthesis is denied those aminoacids. Such situations might be imitated through the administration of excess nucleosides and (within limits) the simultaneous restriction of some selected aminoacids. DNA replication depends on the stabilization of
p53
, but an accumulation of pre-rRNA might occur, which ultimately might be harmful for cancer cells. Several ways to improve this rationale might be tested on cultured cells and on research animals. They include the destruction of
methionine
with bacterial enzymes, or the addition of ornithine, a precursor of putrescine, which is an important factor of DNA and pre-rRNA synthesis.
...
PMID:Could the loss of regulation of genetic expression in cancer cells be used to cause their necrosis? 385 85
p53
, a transformation-related cellular-encoded protein, was found to accumulate at high concentration in transformed cell lines. The results presented here show that
p53
biosynthesis is also increased in most induced and spontaneous mouse tumors. Judged by the identity in antigenic determinants (estimated by binding to monoclonal antibodies), size, and partial peptide mapping, I conclude that the
p53
molecule found in primary tumors is indistinguishable from that in established cell lines. The fact that
p53
is found in heterogeneous populations of primary tumors makes it a convenient biochemical diagnostic marker for the detection of primary tumors in mice. It is found in primary tumors as a phosphoprotein, just as it was found previously in established cell lines. On the other hand, the
p53
found at low concentration in normal thymocytes is labeled with [35S]
methionine
but cannot be found in its phosphorylated form.
...
PMID:p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells. 618 26
Herpesvirus saimiri particles were purified from productively infected owl monkey kidney cell cultures, and the virion polypeptides were analyzed by polyacrylamide gel electrophoresis. A total of 21 predominant proteins were found in lysates of H. saimiri 11 particles by Coomassie blue staining or by [35S]
methionine
labeling and autoradiography; all proteins were between 160,000 and 12,000 daltons in size. They are most probably virion constituents, as most of them were precipitated by immune sera, and no dominant proteins of equivalent sizes were found in mock-infected cultures. Four glycoproteins (gp 155/160, gp 128, gp 84/90, gp 55) and three polypeptides that appeared not to be glycosylated (p71, p35, p28) were assigned to the envelope or matrix of virions, whereas at least four phosphoproteins (pp132, pp118, pp55, pp13) and ten polypeptides without apparent secondary modification (p155/160, p106, p96, p67,
p53
, p36, p32, p15, p14, p12) were found in the nucleocapsid fraction. Analysis of virion proteins from different H. saimiri strains did not reveal appreciable differences in the migration behavior of most polypeptides, including all glycoproteins; however, determination of a strain-specific size pattern was possible for three of four phosphoproteins. The overall similarity in protein architecture of H. saimiri strains obviously does not reflect the variability in biology, such as oncogenic properties. In comparison, DNA sequence divergences appear to remain a better taxonomic criterion for strain distinction.
...
PMID:Structural proteins of Herpesvirus saimiri. 631 78
Several SV40-transformed FR 3T3 rat cell lines formed tumors upon inoculation to syngeneic immunocompetent Fisher rats. These tumors, which appeared only after a long latency period, showed a fast rate of growth. Tumor-derived (TD) cell lines were established in culture from several tumors induced by independent transformants, and their properties were analyzed. Though TD cells were highly tumorigenic, their level of transformation in culture was similar to that of the original transformants. They did not synthesize detectable amounts of the two early viral gene products, the large-T and small-T polypeptides. However, the transformation-associated cellular
p53 protein
was detected in all of them by [35S]
methionine
labeling and immune precipitation with monoclonal antibodies directed against the mouse
p53
. Growth in the animal apparently counterselected the cells expressing the early viral proteins, and hence, possibly, the tumor-specific transplantation antigen. This selection was mediated at least in part by the T-cell immune response, as the tumors induced by the same transformants in nu/nu mice still expressed the nuclear T-antigen. Absence of expression of the early viral region was frequently correlated with the loss of the integrated SV40 DNA. Some tumors, however, still contained early viral DNA sequences, which were, in even fewer cases, transcribed into RNA. These results altogether suggest that tumor formation by the FR 3T3-SV40 transformed cells in immunocompetent rats requires two events, the selection for the acquisition of a high tumorigenic potential, and against the expression of the early viral genes. Only the first of these two events was observed upon tumor formation in nude mice.
...
PMID:Cell lines derived from tumors induced in syngeneic rats by FR 3T3 SV40 transformants no longer synthesize the early viral proteins. 632 54
The subcellular localization of the
p53
molecule was studied in transformed and non-transformed fibroblasts. A newly established transformed cell line obtained by treating primary embryonic mouse cells in vitro with the chemical carcinogen methylcholanthrene was compared with the embryonic parent fibroblasts. The transformed cells lost the spindle shape characteristic of the parent fibroblasts, acquired an accelerated growth rate, developed into tumors when injected into syngeneic mice and expressed high levels of
p53
synthesis estimated by immunoprecipitation of [35S]
methionine
-labeled cell extracts. The cellular localization of the
p53
molecule was studied by immunofluorescent staining of fixed cells with monoclonal antibodies and by immunoprecipitation of [35S]-
methionine
-labeled
p53
from various subcellular fractions.
p53
was mainly found in the nucleus of the transformed fibroblast, while in the parent non-transformed primary embryonic cells,
p53
was detected in the cytoplasm in a Triton X-100 soluble fraction, and associated with the cytoskeleton. The modulated distribution of
p53
was also confirmed by analyzing a wide range of independently established transformed and non-transformed fibroblastic cell lines growing in vitro. The switch from the cytoplasmic localization of
p53
in the non-transformed fibroblasts to a chromatin-associated accumulation in the transformed cells suggests a possible mechanism by which this protein may function in the transformed fibroblasts.
...
PMID:P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts. 635 6
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>